Management of Foreign Body Aspiration in Children: Insights From 664 Cases in the Operating Room

Tracheal or bronchial foreign body aspiration is an important emergency o childhood requiring bronchoscopy under general anesthesia. In this retrospective study, bronchoscopy were performed for foreign body aspiration; anesthesia methods, risks, and postoperative complications were evaluated. Children who underwent bronchoscopy with suspicion of a foreign body in the pediatric surgery operating room between January 2010 and December 2021 were included in the study. Six hundred and sixty four children were evaluated. General anesthesia was applied to all bronchoscopy. Demographic characteristics of the patients, type of foreign body, localization of foreign body, distribution of foreign body according to age groups, complications related to anesthesia and surgical process, length of stay in the postoperative intensive care unit, and duration of hospital stay were evaluated. The patients who aspirated foreign bodies most frequently were children aged 1-3 years (73.6%). During bronchoscopy, organic matter (seeds, hazelnuts, peanuts, chickpeas) was the most frequently removed foreign body in children (559 patients). It was observed that foreign bodies were mostly located in the right main bronchus at a rate of 52.4%, the left main bronchus at 28%. The most common anesthesia-related complications were desaturation in 400 patients, hypercarbia in 200 patients, bronchospasm in 108 patients, and respiratory arrest in 2 patients. Many problems may be encountered in foreign body inhalation, and bronchoscopy of these patients should be performed by an experienced anesthesiologist and surgeon at the right time and in the safest way in terms of anesthesia and surgery

Addition of dexmedetomidine to bupivacaine in supraclavicular brachial plexus block

Purpose: Research is ongoing to determine the lowest dose of local anesthetics in brachial plexus block that provides adequate anesthesia and postoperative analgesia and reduces complications related to local anesthetics

Laparoskopik kolesistektomi sonrası postoperatif bulantı ve kusmanın önlenmesindetropisetron ve palonosetron’un karşılaştırılması: Randomize, çift-kör çalışma

&Ouml;ZETAma&ccedil;: Postoperatif bulantı-kusma (POBK) anestezi sonrasıen sık ortaya &ccedil;ıkan yan etkilerden biridir. POBK hastanınameliyat sonrası derlenmesini ve hastanede kalışs&uuml;resini uzatır. Bu &ccedil;alışmada, intraoperatif uygulanantropisetron ve palonosetronun, laparoskopik kolesistektomisonrası postoperatif bulantı kusma &uuml;zerine etkilerininkarşılaştırılması ama&ccedil;landı.Y&ouml;ntemler: Laparoskopik kolesistektomi planlanan, ASAI-II grubu, 18-65 yaş arası 142 hasta &ccedil;alışmaya dahiledildi. Endotrakeal ent&uuml;basyon sonrası iv yoldan PalonosetronGrubuna (Grup P) 0.075 mg palonosetron,Tropisetron Grubuna (Grup T) iv 5 mg tropisetron verildi.Hastaların postoperatif 0-72 saatlik zaman diliminde bulantı-kusma skorları, antiemetik kullanımları ve VAS skorlarıkaydedildi.Bulgular: Vakaların postoperatif 0-24 ve 48-72 saatlikd&ouml;nemdeki bulantı-kusma skorları arasında gruplar arasındaistatistiksel fark bulunmazken (p &gt; 0.05), 24-48 saatlikd&ouml;nemde ise Grup P&rsquo;de, Grup T&rsquo;ye g&ouml;re bulantı-kusmaskorları daha d&uuml;ş&uuml;k bulundu (p &lt; 0.024) (Tablo 3).Postoperatif antiemetik kullanımı a&ccedil;ısından 72 saattekiher bir d&ouml;nemde gruplar arasında fark yoktu (p &gt; 0.05).72 saatlik toplam ek antiemetik t&uuml;ketimi ise Grup T&rsquo;de,Grup P&rsquo;ye g&ouml;re istatistiksel olarak anlamlı y&uuml;ksek bulundu(p = 0.025) (Tablo 4).Sonu&ccedil;: POBK profilaksisinde antiemetik olarak kullanılanpalonosetron, postoperatif 24-48 saatler arasında POBKşiddet skorunu ve toplam postoperatif 72 saatteki ek antiemetikihtiyacını tropisetrona g&ouml;re daha fazla azaltmıştır.ABSTRACTObjective: Postoperative nausea-vomiting (PONV) isone of the most common side effects after anesthesia.PONV extends the duration of hospital stay and recoverytime of the patient after the surgery. In this study, wecompared the effects of tropisetron on palonosetron onpostoperative nausea and vomiting after laparoscopiccholecystectomy.Methods: After endotracheal intubation, PalonosetronGroup (Group P) received iv 0.075 mg of palonosetronand Tropisetron Group (Group T) received iv 5 mg of tropisetron.VAS scores, antiemetic use and nausea-vomitingscores were recorded in 0-72 hours interval.Results: In the 0-24 and 48-72 hour intervals, there wereno statistical difference between the groups with respectto nausea-vomiting scores, but, in the 24-48 hour interval,nausea-vomiting score was lower in Group P than GroupT (p &lt; 0.024) (Table 3). There was no statistical differencein all 72 hour intervals with respect to antiemetic use (p &gt;0.05). 72 hours total antiemetic use was statisticaly higherin Group T than Group P (p = 0.025) (Tablo 4).Conclusion: For PONV prophylaxis, palonosetron decreasedthe PONV score and antiemetic need more thantropisetron in the first 72 hours.</p

Laparoskopik kolesistektomi sonrası postoperatif bulantı ve kusmanın önlenmesinde tropisetron ve palonosetron’un karşılaştırılması: Randomize, çift-kör çalışma

Objective: Postoperative nausea-vomiting (PONV) is one of the most common side effects after anesthesia. PONV extends the duration of hospital stay and recov­ery time of the patient after the surgery. In this study, we compared the effects of tropisetron on palonosetron on postoperative nausea and vomiting after laparoscopic cholecystectomy. Methods: After endotracheal intubation, Palonosetron Group (Group P) received iv 0.075 mg of palonosetron and Tropisetron Group (Group T) received iv 5 mg of tro­pisetron. VAS scores, antiemetic use and nausea-vomit­ing scores were recorded in 0-72 hours interval. Results: In the 0-24 and 48-72 hour intervals, there were no statistical difference between the groups with respect to nausea-vomiting scores, but, in the 24-48 hour interval, nausea-vomiting score was lower in Group P than Group T (p < 0.024) (Table 3). There was no statistical difference in all 72 hour intervals with respect to antiemetic use (p > 0.05). 72 hours total antiemetic use was statisticaly higher in Group T than Group P (p = 0.025) (Tablo 4). Conclusion: For PONV prophylaxis, palonosetron de­creased the PONV score and antiemetic need more than tropisetron in the first 72 hours